• news.cision.com/
  • Attana/
  • New paper using Attana Technology to study structures on surface in Ion Liquids demonstrating the effect of surface charges on interaction properties.

New paper using Attana Technology to study structures on surface in Ion Liquids demonstrating the effect of surface charges on interaction properties.

Report this content

In the paper in "Journal of Colloid And Interface Science", the Attana quartz crystal microbalance (QCM) is applied to study the electrical response of two ionic liquids. Controlled by an applied electric field, the structure and interaction of ionic liquids on the surface, can be monitored and optimized. This is of high importance for the development of e.g. environment friendly lubricants. This is the third paper by the team of Prof Rutland that demonstrates how Attana technology can be applied to monitor interaction properties by changing the electrical potential at surfaces.

 

For drug development this is of importance because many interactions in the human body are strongly affected by electrical charges at e.g. the cell surfaces. The pH of human liquids is different, e.g in the blood stream or inside a cell, and that effects the surface charges. Therefore, there is a potential for drug development to tailor local charges on drug molecules such as antibodies, which can then be applied to minimize off-target interactions or improve target interactions. Thanks to Prof. Rutland's work Attana technology can be applied to optimize drug properties with respect to electrostatic interactions.

 

 

En bild som visar illustration, design

Automatiskt genererad beskrivning med låg exakthetEn bild som visar text, skärmbild, linje, diagram

Automatiskt genererad beskrivning

For more information, please contact:

Marcus Söderberg

CEO Attana AB
ir@attana.com


+46 708 86 23 00

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.

About Attana

Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact sales@attana.com

Tags:

Subscribe

Media

Media

Documents & Links